Andrew P. Blanchard

Substrate-Dependent Modulation of CYP3A4 Catalytic Activity: Analysis of 27 Test Compounds with Four Fluorometric Substrates

David M. Stresser, Andrew P. Blanchard, Stephanie D. Turner et al. · Drug Metabolism and Disposition · 2000 · 276 citations

Medicine, Pharmacokinetics, Pharmacology +17

Cytochrome P450 Fluorometric Substrates: Identification of Isoform-Selective Probes for Rat CYP2D2 and Human CYP3A4.

David M. Stresser, Stephanie D. Turner, Andrew P. Blanchard et al. · Drug Metabolism and Disposition · 2002 · 162 citations

Medicine, Biochemistry, Pharmacology +16

HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE

David M. Stresser, Marc I. Broudy, Thuy Ho et al. · Drug Metabolism and Disposition · 2004 · 128 citations

Medicine, Medicinal Chemistry, Pharmacology +15

HUMAN CYTOCHROME P450 INDUCTION AND INHIBITION POTENTIAL OF CLEVIDIPINE AND ITS PRIMARY METABOLITE H152/81

George Zhang, Shangara S. Dehal, Thuy Ho et al. · Drug Metabolism and Disposition · 2006 · 40 citations

Medicine, Pharmacokinetics, Pharmacology +17

Development and validation of a Level A in-vitro in-vivo correlation for tofacitinib modified-release tablets using extrudable core system osmotic delivery technology

Joseph Kushner, Manisha Lamba, Thomas Stock et al. · European Journal of Pharmaceutical Sciences · 2019 · 25 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17